![Roger Strair](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roger Strair
Corporate Officer/Principal at Rutgers Cancer Institute of New Jersey
Profile
Roger Strair currently works at Rutgers Cancer Institute of New Jersey, as Chief-Blood Disorders Medical Oncologist from 1993.
Roger Strair active positions
Companies | Position | Start |
---|---|---|
Rutgers Cancer Institute of New Jersey
![]() Rutgers Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is the only National Cancer Institute-designated comprehensive cancer center in New Jersey. Rutgers Cancer Institute has locations in New Brunswick and at University Hospital in Newark, as well as through RWJBarnabas Health facilities. The institute offers advanced cancer treatment options, including bone marrow transplantation, proton therapy, CAR T-cell therapy, and complex surgical procedures. Patients have access to cutting-edge therapies such as precision medicine and immunotherapy, many of which are not widely available. The top cancer researchers and clinicians throughout the state collaborate to apply the latest technologies, therapies, and approaches to improve cancer diagnosis and treatment. | Corporate Officer/Principal | 1992-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Rutgers Cancer Institute of New Jersey
![]() Rutgers Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is the only National Cancer Institute-designated comprehensive cancer center in New Jersey. Rutgers Cancer Institute has locations in New Brunswick and at University Hospital in Newark, as well as through RWJBarnabas Health facilities. The institute offers advanced cancer treatment options, including bone marrow transplantation, proton therapy, CAR T-cell therapy, and complex surgical procedures. Patients have access to cutting-edge therapies such as precision medicine and immunotherapy, many of which are not widely available. The top cancer researchers and clinicians throughout the state collaborate to apply the latest technologies, therapies, and approaches to improve cancer diagnosis and treatment. | Health Services |
- Stock Market
- Insiders
- Roger Strair